Does Qsymia affect vision?
Common side effects of Qsymia include: constipation, insomnia, nasopharyngitis, paresthesia, mood disorder, sleep disorder, and xerostomia. Other side effects include: urinary tract infection, anxiety, blurred vision, depression, dizziness, fatigue, influenza, nausea, increased serum creatinine, and dysgeusia.
Does phentermine cause vision problems?
Stop taking this medication and seek immediate medical attention if any of these rare but very serious side effects occur: severe headache, slurred speech, seizure, weakness on one side of the body, vision changes (e.g., blurred vision).
Does phentermine make your eyes blurry?
Overheating may result in heat stroke. Also, hot baths or saunas may make you dizzy or faint while you are taking this medicine. This medicine may cause your body temperature to go down especially when taking valproic acid, which is a medicine to control seizures.
Does Topamax cause eye problems?
Topamax can cause severe eye conditions that may result in blindness. Acute myopia, which causes nearsightedness, can cause headaches or blurred vision because of increased pressure in the eye.
What happens if you stop taking Qsymia?
Stopping Qsymia suddenly can cause serious problems, such as seizures. Your healthcare provider will tell you how to stop taking Qsymia slowly. If you take too much Qsymia, call your healthcare provider or go to the nearest emergency room right away.
Can diet pills cause blurred vision?
increased blood pressure and heart rate. insomnia (trouble sleeping) nervousness. blurred vision.
Can Topamax cause double vision?
Diplopia and nystagmus have been reported in 14% to 15% of patients using high doses of topiramate (3). Although the dose of the drug was low (25 mg 2x daily) in our case, diplopia developed.
Is it OK to take Qsymia every other day?
To stop Qsymia, patients should take a dose (determined by your doctor) every other day for at least 1 week and then before stopping stop treatment altogether.
How long do the side effects of Qsymia last?
These events typically began within the first 4 weeks of treatment, had a median duration of approximately 28 days or less, and were reversible upon discontinuation of treatment; however, individual patients did experience events later in treatment, and events of longer duration.
